21% Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules Get link Facebook X Pinterest Email Other Apps GlobeNewswire Get link Facebook X Pinterest Email Other Apps